title: Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
authors.affiliation: Chair of hematology and chair of medical pathology, Institute of Clinical Medicine, University of Palermo, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tambone Reyes
authors.forename: R
authors.initials: R
authors.lastname: Bonaccorso
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: D
authors.initials: D
authors.lastname: Tinnirello
authors.forename: V
authors.initials: V
authors.lastname: Di Salvo
authors.forename: A
authors.initials: A
authors.lastname: Ciulla
authors.forename: P
authors.initials: P
authors.lastname: Di Marco
authors.forename: S
authors.initials: S
authors.lastname: Mansueto
authors.forename: P
authors.initials: P
authors.lastname: Citarrella
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000754:Anemia, Refractory, with Excess of Blasts / Q000188:drug therapy; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine